Statement by Minister St-Onge on Human Rights Day
On Human Rights Day, let’s work together to promote freedom, equality and justice for every person. OTTAWA, ON, Dec. 10, 2023 /CNW/ – Today, on Human Rights Day, the Honourable Pascale St-Onge, Minister of Canadian Heritage made the following statement. “The Government of Canada
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com
Freedom, Equality and Justice Lead to Peace
Human Rights Day Statement by Education Cannot Wait Executive Director Yasmine Sherif NEW YORK, Dec. 10, 2023 /PRNewswire/ — Today we mark a milestone in history: the 75th anniversary of the Universal Declaration of Human Rights. As people around the world commemorate Human Rights Day, we must
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRNQ
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capstone Green Energy Corporation (“Capstone” or the “Company”) (OTC: CGRNQ). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On InMode Ltd.- INMD
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. T
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DMC Global Inc. – BOOM
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-652
ILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional
CAPSTONE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Capstone To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Capstone securities between June 14, 2021 and September 22, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additio
DERMTECH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in DermTech stock or options between March 8, 2021 and November 3, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for addi
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
CAIRO and PARIS, Dec. 10, 2023 /PRNewswire/ — Sanofi and Minapharm announce the signing of an exclusive Manufacturing and Supply Agreement for the localization of the full range of its flagship market leader product, Clexane®. The agreement between Sanofi, a global pharmaceutical company and
